The UK government’s new Life Sciences Vision “entirely ignores” the off-patent industry, representing an “astonishing” snub given the value of the sector to the NHS and its critical role in fighting the COVID-19 pandemic, according to BGMA chief Mark Samuels.
Mark Samuels, CEO of the British Generic Manufacturers Association, has slammed the UK government after an extensive “Life Sciences Vision” strategy document published yesterday contained no measures geared towards the off-patent sector.
“A key theme from the government’s vision for life sciences is that it addresses and supports the diversity of the...
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Also, Latest News From Europe, Canada, Saudi Arabia, Finland, China, And The US
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
